ns 1619 has been researched along with Erectile Dysfunction in 2 studies
NS 1619: structure given in first source
NS 1619 : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one in which the hydrogens at positions 1 and 5 are replaced are replaced by 2-hydroxy-5-(trifluoromethyl)phenyl and trifluoromethyl groups, respectively. It is an opener/activator of the large-conductance calcium-activated potassium channel (Bkca).
Erectile Dysfunction: The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Corrochano, R | 1 |
| La Fuente, J | 1 |
| Cuevas, P | 1 |
| Fernández, A | 1 |
| Chen, M | 1 |
| Sáenz de Tejada, I | 1 |
| Angulo, J | 1 |
| Spektor, M | 1 |
| Rodriguez, R | 1 |
| Rosenbaum, RS | 1 |
| Wang, HZ | 1 |
| Melman, A | 1 |
| Christ, GJ | 1 |
2 other studies available for ns 1619 and Erectile Dysfunction
| Article | Year |
|---|---|
Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.
Topics: Adult; Aged; Animals; Benzimidazoles; Carbolines; Cyclic GMP; Diabetes Mellitus, Experimental; Dose- | 2013 |
Potassium channels and human corporeal smooth muscle cell tone: further evidence of the physiological relevance of the Maxi-K channel subtype to the regulation of human corporeal smooth muscle tone in vitro.
Topics: Benzimidazoles; Cells, Cultured; Charybdotoxin; Electrophysiology; Erectile Dysfunction; Humans; In | 2002 |